• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Gaps in evidence-based therapy use in patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease

byJack LennonandAlex Chan
January 21, 2021
in Cardiology, Endocrinology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Associations remain inconclusive between religiosity and spirituality on medication adherence in cardiovascular disease

2 Minute Medicine Rewind, May 16

2 Minute Medicine Rewind April 9, 2022

1. Significant gaps were found in the use of evidence-based therapies in insured patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus.

Evidence Rating Level: 2 (Good)

Prevalence of atherosclerotic cardiovascular disease (ASCVD) in patients with type 2 diabetes mellitus (T2DM) is twice as high as those without T2DM, resulting in worse health outcomes and premature death. Several classes of medications have proven efficacy for individuals with ASCVD and T2DM, such as angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), high-intensity statins, sodium glucose cotransporter-2 inhibitors (SGLT-2is), and glucagon-like peptide-1 receptor agonists (GLP-1RAs). However, evidence suggests that these medications are underutilized with this population. A total of 699,380 patients with T2DM insured with Anthem on April 30, 2018 and enrolled for a period of 12 months thereafter were included in this cohort study. Among these, 155,958 had evidence of ASCVD and were greater than 18 years of age without chronic kidney disease stage 4 or 5. The primary outcome was the proportion of patients with prescription claims for each of the three classes of evidence-based therapy on, or covering, the index date ±30 days: ACEI/ARB (or angiotensin receptor-neprilysin inhibitor), high-intensity statin (atorvastatin 40-80mg or rosuvastatin 20-40mg), and SGLT-2i or GLP-1RA. Of the patients in this sample, 24.7% were using a high-intensity statin, 53.1% were using an ACEI/ARB, and 9.9% were using a SGLT-2i or GLP-1RA. Only 2.7% of the population were covered by prescriptions for all three therapies; 37.4% were on none of these therapies. Over the course of 12 months, only 18% visited an endocrinologist while 70.6% had visited a cardiologist. Lastly, the potential benefit of achieving 100% adoption of the three therapies was simulated using pooled treatment estimates from clinical trials. Increasing the use of these evidence-based therapies to 100% over three years of treatment could reduce 4,546 major atherosclerotic cardiovascular events, such as stroke, myocardial infarction, or cardiovascular death, in eligible but untreated patients. Overall, this study found significant deviations from contemporary use of the three evidence-based therapies in insured patients with T2DM and ASCVD.

Click to read the study in JAHA

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiologydiabetes
Previous Post

#VisualAbstract: Retrospective study identifies common hospital complications associated with COVID-19

Next Post

#VisualAbstract Higher rate of hematologic second primary malignancies developed in multiple myeloma patients who received autologous hematopoietic stem cell transplants

RelatedReports

Cardiology

Associations remain inconclusive between religiosity and spirituality on medication adherence in cardiovascular disease

May 16, 2022
Image-guided percutaneous drainage of pericardial effusions is safe and effective
Weekly Rewinds

2 Minute Medicine Rewind, May 16

May 16, 2022
Weekly Rewinds

2 Minute Medicine Rewind April 9, 2022

May 9, 2022
Classics Series, Landmark Trials in Medicine
Emergency Classics

The ACCORD trial: Intensive glucose control associated with increased mortality [Classics Series]

May 4, 2022
Next Post
#VisualAbstract Higher rate of hematologic second primary malignancies developed in multiple myeloma patients who received autologous hematopoietic stem cell transplants

#VisualAbstract Higher rate of hematologic second primary malignancies developed in multiple myeloma patients who received autologous hematopoietic stem cell transplants

#VisualAbstract: Chemotherapy in addition to local therapy may improve overall survival in patients aged 70 years or older with  triple-negative breast cancer

#VisualAbstract: Long-term pembrolizumab monotherapy maintains efficacy despite the occurrence of immune-related adverse events in patients with advanced melanoma

Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress

Increases in p-tau181 in blood plasma associated with progressive, longitudinal neurodegeneration

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial
  • #VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
  • #VisualAbstract: Segmentectomy is superior to lobectomy for patients with early-stage non-small cell lung cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.